Vonoprazan treatment improves gastrointestinal symptoms in patients with gastroesophageal reflux disease.

Kaohsiung J Med Sci · 2017 · PMC11915918 · PMID 29132551

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The rates of improvement and resolution for epigastric pain had a greater trend than for postprandial distress, although it did not reach statistical significance.

also in 78,910 other papers

a favorable trendno p-value reported

Vonoprazan also showed a favorable trend in the improvement of lower GI symptoms including constipation and diarrhea in this study.

also in 1,053 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.